What are the compliance requirements for sequence listings in patent applications?

Question

Accepted Answer

Source: FAQ (MPEP-Based) BlueIron Update: 2024-09-30 10 Rules 5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. According to MPEP 2422.07 , patent applications must comply with the requirements of 37 CFR 1.821(b) through (e) for sequence listings. The section states: “37 CFR 1.821(g) requires compliance with the requirements of 37 CFR 1.821(b) through (e) , as discussed above, if they are not satisfied at the time of filing under 35 U.S.C. 111(a) or at the time of entering the national stage of an international application under 35 U.S.C. 371 , within the period of time set in a notice requiring compliance.” This means that if the sequence listing requirements are not met at the time of filing, applicants must comply within a specified period. Related Rules from the Manual of Patent Examining Procedure 10 rules Collapse Compliance with Sequence Listing and CRF Required MPEP 2422.07 Filing Requirements for Sequence Listings Differ Between Applications MPEP 2422 Recommended Sequence Listing Must Comply with WIPO ST.25 (2009) MPEP 2422 Recommended Sequence Listing and CRF Required for Compliance MPEP 2422.07 Applicants Must Comply with No New Matter Prohibition MPEP 2422.07 Application Must Comply with Filing Requirements MPEP 2422 Extension of Time for Compliance with Requirements MPEP 2422.07 Sequence Listing and CRF Copy Must Be Filed According to 37 CFR 1.825 MPEP 2422.07 Required Appendices A-F for Sequence Listings Required MPEP 2422 Sequence Listing Required for PCT Filing MPEP 2422 Permitted Other Related FAQs 5 FAQs Collapse What are the consequences of submitting non-compliant sequence listings in a patent application? What are the consequences of submitting a sequence listing that does not comply with 37 CFR 1.821-1.825? Can corrections be made to sequence listings after filing? Are provisiona...